د.ايناس الحضيري2024-12-042024-12-04https://dspace.academy.edu.ly/handle/123456789/505Methods: This study included 294 HD patients and 76 healthy people. Patients were tested for anti-SARS-CoV-2 IgG antibodies after receiving one, two, or three doses of the COVID-19 vaccine or after COVID-19 infection.Background: People on haemodialysis (HD) are at higher risk of severe illness from COVID-19. Their immune response to infections may be weak and may have an attenuated response to vaccines. Objective: To measure the levels of anti-SARS-CoV-2 IgG antibodies in HD patients after COVID-19 vaccination or infection.humoral immune response